Robin joined Agendia in January 2017 and has more than thirty years of experience in quality and regulatory affairs in the biotechnology industry.  Prior to joining Agendia, she served as Senior Vice President, Corporate Governance and Regulatory Affairs at Sequenom prior to its acquisition by Laboratory Corporation of America.  Prior to this position, Robin was the Vice President of Regulatory and Government Affairs at Biosite Incorporated, prior to its acquisition by Alere.  From 1982 to 2004, Robin held positions of increasing responsibility at Quidel Corporation, most recently serving as Vice President, Clinical and Regulatory Affairs.

Robin earned a B.A from the University of California, San Diego and a M.B.A. from National University.